Asset Manager

Updated:

Health Care Originals

Sharon Samjitsingh's Health Care Originals combines a wearable lung tracker with virtual respiratory therapy in direct-to-patient chronic-care...

Health Care Originals

Health Care Originals was co-founded by Sharon and Jared Samjitsingh in Rochester, New York. Sharon has managed severe asthma since birth, experiencing multiple near-death episodes; that history drives the firm's focus on patient-centered respiratory care rather than device sales alone. The company's "Why" statement frames its work as a mission to serve over 500 million people worldwide living with chronic respiratory conditions, a number they expect to grow with climate change. HCO operates across two main business lines. ADAMM (Automated Device for Asthma Monitoring and Management) is a wearable sensor that tracks coughing, wheezing, respiratory rate, and activity patterns, translating them into lifestyle and medication guidance through a companion app. The Nightingale Virtual Respiratory Care service pairs device data with regular access to respiratory therapists and health-and-wellness coaches via 12-month subscription plans branded as Hover and Fly. Geographically, the firm serves the United States from its Rochester headquarters and deploys ADAMM-RSM for clinical trials, collecting real-world evidence across diverse populations. HCO remains a compact operation — the company describes most of its team as personally affected by respiratory conditions. No outside capital structure, fund vehicles, or institutional investment partnerships are disclosed on the firm's website. The absence of named allocators or deployment figures suggests the firm may operate as a bootstrapped or privately financed health-tech venture rather than a traditional investment management entity. Structurally, HCO diverges from standard digital-health plays by selling clinical-trial data services and direct-to-consumer care subscriptions under one roof. That hybrid model — medical-device R&D, real-world evidence generation, and ongoing patient care — gives the firm a recurring revenue stream tied to chronic disease maintenance rather than episodic treatment.

Website
ndh.health

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Rochester

Corporate office

Rochester, NY, United States

Principals

Sharon Samjitsingh

Co-Founder

Jared Samjitsingh

Co-Founder

Sector focus

Digital Health

Frequently asked questions

What is ADAMM and how does it fit into Health Care Originals' offering?

ADAMM is a wearable device that monitors respiratory parameters — cough frequency, wheeze, activity, and breathing patterns — and feeds data into a mobile app. The system translates these signals into personalized recommendations for medication timing and lifestyle adjustments. HCO also deploys a clinical-trial version, ADAMM-RSM, to collect real-world evidence for research sponsors.

Does Health Care Originals operate as an investment firm or a health-tech operating company?

The firm functions as an operating company, not an investment manager. It develops and sells a respiratory care service directly to patients and clinical-trial sponsors. No fund structures, limited partners, or deployment figures are disclosed on its corporate website.

Who leads Health Care Originals?

Co-Founders Sharon and Jared Samjitsingh lead the company. Sharon, who has lived with severe asthma since birth, drives the clinical and care-delivery vision. Jared's specific operational role is not detailed on the firm's website beyond his co-founder designation.

What is the Nightingale care program?

Nightingale is HCO's direct-to-patient virtual respiratory care service. Subscribers choose a 12-month care plan — Hover or Fly — that includes smart-device tracking, an onboarding session with a respiratory therapist, and monthly therapist or health-coach sessions. The service targets asthma and COPD patients seeking ongoing disease management.

How does Health Care Originals generate revenue?

Revenue comes from two disclosed channels: direct-to-consumer subscription plans for the Nightingale service, and ADAMM-RSM contracts with clinical-trial sponsors that require real-world respiratory monitoring data. No institutional investment partnerships or fund-management fees are mentioned publicly.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo